A presentation on the safety and efficacy evaluation of atopic dermatitis was held at the American Academy of Dermatology (AAD) in March, and it has been featured in the “Health Industry Distribution Newspaper” issue 1111 (published on 4\/25). We plan to continue utilizing Novel Glycerin Compounds (ozonized glycerin) extensively in the business ventures undertaken by our group companies in the […]<\/p>\n","protected":false},"author":1,"featured_media":2080,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[105,75],"tags":[],"class_list":["post-3443","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-newsroom-en"],"yoast_head":"\n
Presentation on the Efficacy of Novel Glycerin Compounds for Atopic Dermatitis at AAD - Mediplus Pharma, Inc.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Presentation on the Efficacy of Novel Glycerin Compounds for Atopic Dermatitis at AAD - Mediplus Pharma, Inc.\" \/>\n<meta property=\"og:description\" content=\"A presentation on the safety and efficacy evaluation of atopic dermatitis was held at the American Academy of Dermatology (AAD) in March, and it has been featured in the “Health Industry Distribution Newspaper” issue 1111 (published on 4\/25). We plan to continue utilizing Novel Glycerin Compounds (ozonized glycerin) extensively in the business ventures undertaken by our group companies in the […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/\" \/>\n<meta property=\"og:site_name\" content=\"Mediplus Pharma, Inc.\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-22T00:04:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-22T00:05:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2022\/06\/News-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"610\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Mediplus Pharma\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/\",\"url\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/\",\"name\":\"Presentation on the Efficacy of Novel Glycerin Compounds for Atopic Dermatitis at AAD - Mediplus Pharma, Inc.\",\"isPartOf\":{\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2022\/06\/News-1.png\",\"datePublished\":\"2024-05-22T00:04:49+00:00\",\"dateModified\":\"2024-05-22T00:05:08+00:00\",\"author\":{\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/6b64defb6ffc8a545a1aa0d1a36a5d9e\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/#primaryimage\",\"url\":\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2022\/06\/News-1.png\",\"contentUrl\":\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2022\/06\/News-1.png\",\"width\":1600,\"height\":610},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"\u30db\u30fc\u30e0\",\"item\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/home\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Presentation on the Efficacy of Novel Glycerin Compounds for Atopic Dermatitis at AAD\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/#website\",\"url\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/\",\"name\":\"Mediplus Pharma, Inc.\",\"description\":\"Passion for Sustainable Future By Novel Glycerin Compounds. Mediplus pharma, Inc.\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/6b64defb6ffc8a545a1aa0d1a36a5d9e\",\"name\":\"Mediplus Pharma\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/f1f0541f736ea63a92287f69d757275b?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/f1f0541f736ea63a92287f69d757275b?s=96&d=mm&r=g\",\"caption\":\"Mediplus Pharma\"},\"sameAs\":[\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\"],\"url\":\"https:\/\/www.mediplus-pharma.co.jp\/en\/author\/mpp-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Presentation on the Efficacy of Novel Glycerin Compounds for Atopic Dermatitis at AAD - Mediplus Pharma, Inc.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/","og_locale":"en_US","og_type":"article","og_title":"Presentation on the Efficacy of Novel Glycerin Compounds for Atopic Dermatitis at AAD - Mediplus Pharma, Inc.","og_description":"A presentation on the safety and efficacy evaluation of atopic dermatitis was held at the American Academy of Dermatology (AAD) in March, and it has been featured in the “Health Industry Distribution Newspaper” issue 1111 (published on 4\/25). We plan to continue utilizing Novel Glycerin Compounds (ozonized glycerin) extensively in the business ventures undertaken by our group companies in the […]","og_url":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/","og_site_name":"Mediplus Pharma, Inc.","article_published_time":"2024-05-22T00:04:49+00:00","article_modified_time":"2024-05-22T00:05:08+00:00","og_image":[{"width":1600,"height":610,"url":"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2022\/06\/News-1.png","type":"image\/png"}],"author":"Mediplus Pharma","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/","url":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/","name":"Presentation on the Efficacy of Novel Glycerin Compounds for Atopic Dermatitis at AAD - Mediplus Pharma, Inc.","isPartOf":{"@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/#primaryimage"},"image":{"@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/#primaryimage"},"thumbnailUrl":"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2022\/06\/News-1.png","datePublished":"2024-05-22T00:04:49+00:00","dateModified":"2024-05-22T00:05:08+00:00","author":{"@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/6b64defb6ffc8a545a1aa0d1a36a5d9e"},"breadcrumb":{"@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/#primaryimage","url":"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2022\/06\/News-1.png","contentUrl":"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2022\/06\/News-1.png","width":1600,"height":610},{"@type":"BreadcrumbList","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/presentation-on-the-efficacy-of-novel-glycerin-compounds-for-atopic-dermatitis-at-aad\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"\u30db\u30fc\u30e0","item":"https:\/\/www.mediplus-pharma.co.jp\/en\/home\/"},{"@type":"ListItem","position":2,"name":"Presentation on the Efficacy of Novel Glycerin Compounds for Atopic Dermatitis at AAD"}]},{"@type":"WebSite","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/#website","url":"https:\/\/www.mediplus-pharma.co.jp\/en\/","name":"Mediplus Pharma, Inc.","description":"Passion for Sustainable Future By Novel Glycerin Compounds. Mediplus pharma, Inc.","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.mediplus-pharma.co.jp\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/6b64defb6ffc8a545a1aa0d1a36a5d9e","name":"Mediplus Pharma","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.mediplus-pharma.co.jp\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/f1f0541f736ea63a92287f69d757275b?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f1f0541f736ea63a92287f69d757275b?s=96&d=mm&r=g","caption":"Mediplus Pharma"},"sameAs":["https:\/\/www.mediplus-pharma.co.jp\/_wordpress"],"url":"https:\/\/www.mediplus-pharma.co.jp\/en\/author\/mpp-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/posts\/3443"}],"collection":[{"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/comments?post=3443"}],"version-history":[{"count":2,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/posts\/3443\/revisions"}],"predecessor-version":[{"id":3445,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/posts\/3443\/revisions\/3445"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/media\/2080"}],"wp:attachment":[{"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/media?parent=3443"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/categories?post=3443"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.mediplus-pharma.co.jp\/en\/wp-json\/wp\/v2\/tags?post=3443"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}} ![\"\"](\"https:\/\/www.mediplus-pharma.co.jp\/_wordpress\/wp-content\/uploads\/2024\/05\/image.jpg\")
<\/figure>\n","protected":false},"excerpt":{"rendered":"